Preconditioning: Evolution of basic mechanisms to potential therapeutic strategies

被引:52
作者
Tsai, BM
Wang, MJ
March, KL
Turrentine, MW
Brown, JW
Meldrum, DR
机构
[1] Indiana Univ, Sch Med, Dept Surg, Sect Cardiothorac Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Physiol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[4] Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA
来源
SHOCK | 2004年 / 21卷 / 03期
关键词
cytokines; enclotoxemia; ischemia/reperfusion; myocardial infarction; protection; heat shock; tolerance;
D O I
10.1097/01.shk.0000114828.98480.e0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Preconditioning describes the phenomenon by which a traumatic or stressful stimulus confers protection against subsequent injury. Originally recognized in dog heart subjected to ischemic challenges, preconditioning has been demonstrated in multiple species, can be induced by various stimuli, and is applicable in different organ systems. Tremendous progress has been made elucidating the signal transduction cascade of preconditioning. Preconditioning represents a potent tissue-protective condition, and mechanistic understanding may allow safe clinical application. This review recalls the history of preconditioning and how it relates to the history of the investigation of endogenous adaptation; summarizes the current mechanistic understanding of acute preconditioning; outlines the signal transduction cascade leading to the development of delayed preconditioning; discusses preconditioning in noncardiac tissue; and explores the potential of using preconditioning clinically.
引用
收藏
页码:195 / 209
页数:15
相关论文
共 251 条
[11]   PRECONDITIONING AGAINST MYOCARDIAL DYSFUNCTION AFTER ISCHEMIA AND REPERFUSION BY AN ALPHA-1-ADRENERGIC MECHANISM [J].
BANERJEE, A ;
LOCKEWINTER, C ;
ROGERS, KB ;
MITCHELL, MB ;
BREW, EC ;
CAIRNS, CB ;
BENSARD, DD ;
HARKEN, AH .
CIRCULATION RESEARCH, 1993, 73 (04) :656-670
[12]   Okadaic acid and anisomycin are protective and stimulate the SAP/JNK pathway [J].
Barancik, M ;
Htun, P ;
Schaper, W .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (02) :182-190
[13]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[14]   Time course of delayed myocardial protection after transient adenosine A(1)-receptor activation in the rabbit [J].
Baxter, GF ;
Yellon, DM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (05) :631-638
[15]   ADENOSINE RECEPTOR INVOLVEMENT IN A DELAYED PHASE OF MYOCARDIAL PROTECTION 24 HOURS AFTER ISCHEMIC PRECONDITIONING [J].
BAXTER, GF ;
MARBER, MS ;
PATEL, VC ;
YELLON, DM .
CIRCULATION, 1994, 90 (06) :2993-3000
[16]   INVOLVEMENT OF PROTEIN-KINASE-C IN THE DELAYED CYTOPROTECTION FOLLOWING SUBLETHAL ISCHEMIA IN RABBIT MYOCARDIUM [J].
BAXTER, GF ;
GOMA, FM ;
YELLON, DM .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (02) :222-224
[17]   Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide [J].
Bolli, R ;
Bhatti, ZA ;
Tang, XL ;
Qiu, YM ;
Zhang, Q ;
Guo, Y ;
Jadoon, AK .
CIRCULATION RESEARCH, 1997, 81 (01) :42-52
[18]  
Bolli R, 1996, BASIC RES CARDIOL, V91, P57
[19]  
Bolli R, 1997, CIRC RES, V81, P1094
[20]   The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: Established and putative beneficial actions of a retaliatory metabolite [J].
Bouma, MG ;
vandenWildenberg, FAJM ;
Buurman, WA .
SHOCK, 1997, 8 (05) :313-320